Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gateways to clinical trials.

M Bayés1, X Rabasseda, J R Prous

  • 1mbayes@prous.com

Methods and Findings in Experimental and Clinical Pharmacology
|April 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A report from the World Conference on Lung Cancer (September 6-9, 2015 - Denver, Colorado, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the American Association of Urology Annual Meeting 2015 (May 15-19 - New Orleans, Louisiana, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 73rd Annual Meeting of the American Academy of Dermatology (March 20-24 - San Francisco, California, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the European Association for the Study of the Liver's 50th International Liver Congress (April 22-26 - Vienna, Austria).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the Conference on Retroviruses and Opportunistic Infections (CROI) 2015 (February 23-26--Seattle, Washington, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same author

A report from the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals Annual Meeting (November 14-19 - Boston, Massachusetts, USA).

Drugs of today (Barcelona, Spain : 1998)·2015
Same journal

[Proceedings of the XVIII TASPE Seminar, Granada, Spain, 4-5 February 2010].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment algorithm for gastrointestinal graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Treatment of chronic graft-versus-host disease with protein tyrosine kinase inhibitors].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Classification of chronic graft-versus-host disease].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Pegfilgrastim in hematopoietic stem cell transplantation].

Methods and findings in experimental and clinical pharmacology·2011
Same journal

[Allogeneic transplantation in multiple myeloma patients: results and recommendations in February 2010].

Methods and findings in experimental and clinical pharmacology·2011
See all related articles

This guide provides a comprehensive overview of recent clinical trials across various therapeutic areas. It highlights key drugs and their development status, aiding researchers and clinicians in staying updated on pharmaceutical advancements.

Area of Science:

  • Pharmaceutical Sciences
  • Drug Discovery and Development
  • Clinical Research

Context:

  • Gateways to Clinical Trials serves as a crucial resource for tracking the latest advancements in drug development.
  • This issue compiles data from the Prous Science Integrity portal, focusing on emerging therapeutic agents.
  • The compilation covers a wide spectrum of drugs currently under investigation in clinical trials.

Purpose:

  • To provide an up-to-date catalog of ongoing clinical trials.
  • To inform researchers and healthcare professionals about novel drug candidates and their progress.
  • To facilitate access to information on drugs in various phases of clinical development.

Summary:

  • This publication details numerous drugs undergoing clinical trials, including Adefovir dipivoxil, alefacept, anakinra, aripiprazole, bortezomib, and gefitinib.

Related Experiment Videos

  • It covers a broad range of therapeutic categories, from antivirals and oncology agents to treatments for autoimmune diseases and metabolic disorders.
  • The data reflects the dynamic nature of pharmaceutical research, showcasing drugs like imatinib mesylate, peginterferon alfa-2a, and voriconazole.

    • Impact:

    • Enables researchers to identify potential collaborations and competitive intelligence.
    • Supports evidence-based decision-making in drug development and clinical practice.
    • Facilitates a deeper understanding of the current landscape of pharmaceutical innovation and clinical research.